Syncom Formulations (India) Ltd
Syncom Formul. | 524470
Share Price Chart - Syncom Formulations (India) Ltd
Stock Performance
Ratios
About Company
- Incorporated as a private limited Company in 1988, Syncom Formulations (India) Limited was converted into a public limited Company in June, 1992
- The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency
- Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh
- Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards
- Currently, the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers
- The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations
- Commercial production commenced in Apr
- Promoters are Kedarmal Bankda, Vijay Kumar Bankda and Ajay Kumar Bankda
- In addition to pharmaceutical formulations in the form of tablets, capsules, liquids and dry powders, the company also manufactures injectibles and ear/eye drops on a loan licence basis
- In 1994, the company undertook an expansion programme of setting up a new plant for manufacturing pharmaceutical formulations at Pithampur, Madhya Pradesh
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Syncom Formulations (India) Ltd?
The current share price of Syncom Formulations (India) Ltd (Syncom Formul.) is ₹14.18. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Syncom Formulations (India) Ltd?
The Price-to-Earnings (P/E) ratio of Syncom Formulations (India) Ltd is 14.18. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Syncom Formulations (India) Ltd?
Syncom Formulations (India) Ltd has a 52-week high of ₹19.50 and a 52-week low of ₹10.21. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Syncom Formulations (India) Ltd?
Syncom Formulations (India) Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Syncom Formulations (India) Ltd?
The Earnings Per Share (EPS) of Syncom Formulations (India) Ltd is ₹0.81. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Syncom Formulations (India) Ltd?
Syncom Formulations (India) Ltd has a Return on Equity (ROE) of 15.60%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
